The Gladstone Institutes is an independent and nonprofit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer’s disease.
Gladstone researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the stem cell breakthrough of one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, MD, PhD, to improve drug discovery, personalized medicine and tissue regeneration. .
Founded in 1979, Gladstone is affiliated with the University of California, San Francisco (UCSF) and is located in San Francisco, adjacent to UCSF’s Mission Bay campus. Approximately 450 staff members—including more than 300 scientists—work at Gladstone.
The Latest Updated Research News:
Gladstone Institutes research articles from Innovation Toronto
- Scientists Turn Skin Cells into Heart Cells and Brain Cells Using Drugs – April 29, 2016
- Combining the two most powerful biological tools of the 21st century to Control Gene Expression in Stem Cells – CRISPRi – March 11, 2016
- Human Skin Cells Used to Create Insulin-Producing Pancreatic Cells – January 8, 2016
- Gladstone scientists discover potential new treatment for multiple sclerosis – April 29, 2015
- Transplantation of healthy new brain cells reverses learning and memory loss in Alzheimer’s disease model – July 18, 2014
- Building the Tools that Fight Type 1 Diabetes
- New Breakthrough Prize Awards Millions to Life Scientists
- New hope for Alzheimer’s sufferers as breakthrough allows scientists to grow new brain cells from normal skin
- Scientist Converts Human Skin Cells Into Functional Brain Cells